The investigation by Pomerantz LLP centers on whether Cerebras and its leadership engaged in unlawful business practices leading up to and following the firm’s May 2026 initial public offering. During that IPO, the company sold 30 million shares of Class A common stock at $185.00 per share. The scrutiny intensified on June 24, when the company reported a loss of $0.22 per share for the first quarter, missing analyst projections of a $0.16 loss. Beyond the earnings miss, the company issued a forecast indicating narrower gross margins in its core business operations.

Shareholders reacted sharply to the disclosures, driving the stock price down by $44.46 to close at $182.26. Pomerantz LLP, a firm with a history of litigating corporate misconduct, is currently seeking contact from investors impacted by these events to evaluate potential claims regarding breaches of fiduciary duty or securities violations.